Clinical Epidemiology and Global Health

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

期刊鼓励通讯作者使用CRediT分类法（包含14种角色）说明合著者对稿件的具体贡献。 模型中文摘要

For transparency, we encourage corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administratio…

作者应通过Elsevier声明网站完成利益冲突声明，并在投稿系统的附件上传步骤中上传。 模型中文摘要

Authors should complete the declaration of interest statement using https://declarations.elsevier.com/ and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose: "Declarations of interest: none" in the template. More information.

涉及人类受试者或动物的研究应获得机构伦理委员会批准，且须在稿件正文中声明已获得知情同意。 模型中文摘要

Studies involving human subjects or animals should have received the approval of the institutional ethics committee. A statement to this effect and that informed consent was obtained from participating human subjects must be included in the manuscript text. Please ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration…

发表在CEGH上的稿件成为IndiaClen的永久财产，未经事先书面许可不得以任何形式复制或传播。 模型中文摘要

Clinical Epidemiology and Global Health(CEGH) is the official, peer-reviewed publication of IndiaClen. Manuscripts published in the CEGH become the permanent property of IndiaClen. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No IndiaClen article, in part or whole, may be …

期刊开放获取出版信息请访问其开放获取页面。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.

该期刊采用双盲同行评审流程，稿件通常至少送交两名独立专家评审。 模型中文摘要

This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

为核实合规性，文章可能通过Crossref相似性检查及其他原创性或重复检查软件进行检测。 模型中文摘要

To verify compliance, your article may be checked by Crossref Similarity Check and other originality or duplicate checking software.

预印本若已正式发表，应引用正式出版物；未正式发表的预印本可被引用，但须明确标注并提供预印本DOI。 模型中文摘要

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

临床试验必须在印度临床试验注册库或任一国际认可的注册库中注册，并提供注册号。 模型中文摘要

Clinical trials must be registered in either Indian CT registry or any one of the internationally available registries and the registration number must be provided.